@article{Toback_S-2021_109111,
title = {Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines : an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial},
author = {Toback, S. and Galiza, E. and Cosgrove, C. and Galloway, J. and Goodman, A. and Swift, P. and Rajaram, S. and Graves-Jones, A. and Edelman, J. and Burns, F. and Minassian, A. and Cho, I. and Kumar, L. and Plested, J. and Rivers, E. and Robertson, A. and Dubovsky, F. and Glenn, G. and Heath, P.},
month = {nov},
year = {2021},
abstract = {The safety and immunogenicity profile of COVID-19 vaccines when administered concomitantly with seasonal influenza vaccines have not yet been reported. We therefore aimed to report the results of a substudy within a phase 3 UK trial, by evaluating the safety, immunogenicity, and efficacy of NVX-CoV2373 when co-administered with licensed seasonal influenza vaccines.},
pages = {167-179},
volume = {10},
issue = {2},
journal = {Lancet Respiratory Medicine},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2213-2600(21)00409-4},
}
